Core Viewpoint - The Long Triangle region's medical device regulatory departments have jointly released 12 technical review points for the registration of Class II medical devices, aiming to unify evaluation standards and support the quality and innovation of the medical device industry in the region [1][2]. Group 1: Regulatory Collaboration - The release of the review points is part of the "Long Triangle Regional Medical Device Technical Review Cooperation Agreement," developed through expert discussions and enterprise surveys, addressing the unique characteristics of the regional medical device industry [1]. - The review points cover key products such as dynamic electrocardiogram recorders and gene sequencing library preparation instruments, balancing compliance and innovation needs [1]. Group 2: Impact on Industry - The unified review standards and technical requirements aim to resolve issues related to "standard discrepancies and redundant preparations" faced by enterprises during cross-regional applications, thereby reducing application costs and improving efficiency [1]. - The introduction of cutting-edge product categories like cloud computing platforms and wearable devices aligns closely with the innovation trends of the province's medical device industry, providing robust technical support for the cultivation of high-end medical device industry clusters and the transformation of innovative achievements [1]. Group 3: Future Directions - The provincial drug review and inspection center will continue to uphold its responsibilities, enhance collaboration with regional review institutions, and actively participate in optimizing regional review standards and shared capabilities [2]. - The center aims to align with the actual development of the province's medical device industry, accurately meet enterprise innovation needs, and further optimize review processes to ensure the safety and effectiveness of medical devices, contributing to high-quality industry development [2].
长三角三省一市医疗器械审评部门 联合发布区域医疗器械审评要点
Xin Lang Cai Jing·2026-02-26 16:38